NewLimit, co-founded by Brian Armstrong and Blake Byers, secured $40M for epigenetic research to enhance human ‘healthspan’ by cellular rejuvenation, led by experts Greg Johnson and Jacob Kimmel. The startup’s innovative approach targets extending the period of life spent in good health.

Medical Biotechnologist👨‍🔬🧬
Designer💻

This type of investment and research is aimed at helping people.
13 $DEGEN

Thanks for sharing the article
46 $DEGEN 4U

Thanks for sharing this information with us
28 $DEGEN

Thanks for sharing this information with us

The company, co-founded by prominent figures Brian Armstrong (CEO of Coinbase) and Blake Byers (investor), is dedicated to epigenetic research. Epigenetics studies how genes are expressed without altering the underlying DNA sequence.